Page 2 - H Health Investment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

3D Printing News Unpeeled: A5083-RAM5, Chamlion Raises $34m and Airlements - 3DPrint com | The Voice of 3D Printing / Additive Manufacturing

3D Printing News Unpeeled: A5083-RAM5, Chamlion Raises $34m and Airlements - 3DPrint com | The Voice of 3D Printing / Additive Manufacturing
3dprint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 3dprint.com Daily Mail and Mail on Sunday newspapers.

Benjamin dillenburgerHanna szaboPatrick bedarfH health investmentChamlion technologyVertex venturesHealth investmentZhencheng capitalPrinting chamion

Chamlion completed 236 million yuan in Series B fundraising, building a new eco-system of digital dentistry

/PRNewswire/ Recently, Chamlion, which focuses on the digitalization of the full process of dentistry, announced that it has completed the B round.

Republic ofUnited statesZhijin xiaJianwei liChamlion laser to technologyH health investmentH healthShandong yinling industry investment co ltdVertex ventures chinaZhencheng capitalTaihe capitalHealth investment

China s Alebund Pharmaceuticals snaps over $29m in a pre-Series C round

Alebund has also signed a contract for a syndicated loan of $117m.

Xia guoyaoAlebund pharmaceuticalsYangzhou longchuan holding financial investmentVerition fundH health investmentGuojin groupOctagon capitalQuan capitalLilly asia venturesHuagai capitalLilly asiaBioventures capitalSherpa healthcareGreater china

China Digest: Biotech startup Therorna and HR tech firm Yunsheng snag funds

With the new funding, Therorna has raised a total of over $60 million across three deals.

Yu zengWensheng weiH health investmentTherorna incSchool of life sciences peking universityYunsheng groupVkr holdingsShebao chinaSherpa healthcare partnersHealth investmentQuan capitalSeries pre aLife sciencesPeking universitySequoia capital chinaEnlight growth partners

Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform

/PRNewswire/ Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new.

United statesHong kongYu zengDaniel tangMinchuan wangWensheng weiChangzu caiH healthH health investmentTherorna incWei labSherpa healthcare partnersHealth investmentQuan capitalCenova capitalProfessor wensheng wei